Shao-Di-pa-Ning decoction ameliorates Parkinson’s disease-like pathology and modulates SIRT3 and mitophagy-associated pathways

Objective This study aimed to investigate the neuroprotective effects of Shao-Di-Pa-Ning Decoction (SDPND) in a Parkinson’s disease (PD) mouse model and explore its potential molecular mechanisms, with a particular focus on the regulation of SIRT3/PINK1/Parkin-associated mitochondrial quality-control signaling. Methods Ten-month-old male A53T mice were randomly assigned to the PD model group, SDPND low-, medium-, and high-dose groups (6.956, 13.91, and 27.82 g crude-herb equivalents/kg/day, respectively), and the levodopa/benserazide hydrochloride (LBHT) group (0.1 g/kg/day). Age-matched male C57BL/6 J mice served as the control group. All interventions were administered orally for four consecutive weeks. Behavioral tests, including the pole-climbing and hanging tests, were performed to evaluate motor dysfunction. Immunohistochemistry (IHC) and TUNEL staining were conducted to assess dopaminergic neuronal injury and apoptosis in the substantia nigra. Based on the pharmacological effects observed in the SDPND medium-dose group (13.91 g/kg/day), substantia nigra tissues from control, A53T model, and SDPND medium-dose-treated mice were subjected to transcriptomic sequencing. Differentially expressed genes were identified and analyzed using GO, KEGG, and PPI network analyses to explore the potential molecular mechanisms underlying SDPND-mediated neuroprotection. The effects of SDPND on mitochondrial function, oxidative stress, and mitophagy-related signaling were further validated using transmission electron microscopy (TEM), JC-1 staining, biochemical assays, quantitative real-time PCR (RT-qPCR), and Western blotting. Results SDPND significantly improved motor deficits in A53T mice, increased tyrosine hydroxylase (TH) expression, reduced abnormal α-synuclein accumulation, and attenuated DNA fragmentation in the substantia nigra. Transcriptomic analysis combined with GO, KEGG, and PPI analyses identified mitochondrial function and mitophagy-related pathways as potential targets of SDPND intervention, with SIRT3 emerging as a key regulatory candidate. Further validation demonstrated that SDPND improved mitochondrial morphology, enhanced mitochondrial membrane potential and ATP levels, reduced oxidative stress levels, and increased SIRT3, PINK1, and Parkin expression and the LC3-II/LC3-I ratio, while reducing p62 expression. Conclusion SDPND ameliorates motor dysfunction and neuronal injury in A53T mice. These neuroprotective effects are functionally associated with the modulation of SIRT3/PINK1/Parkin-related signaling and mitophagy-associated markers, alongside improved mitochondrial homeostasis and antioxidant capacity. These findings provide experimental evidence supporting the neuroprotective potential of SDPND, warranting further targeted mechanistic validation.

Authors

Institutions

Publication Details

Journal
Frontiers in Neuroscience
Published
2026-11-16
DOI
https://doi.org/10.3389/fnins.2026.1893994
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Shao-Di-pa-Ning decoction ameliorates Parkinson’s disease-like pathology and modulates SIRT3 and mitophagy-associated pathways

Wenjie Hao, Hu Xi, Ting Dong, Wei Dong et al.
1 links
Frontiers in Neuroscience
Parkinson's Disease Mechanisms and Treatments
article

Shao-Di-pa-Ning decoction ameliorates Parkinson’s disease-like pathology and modulates SIRT3 and mitophagy-associated pathways

Wenjie Hao, Hu Xi, Ting Dong, Wei Dong, Han Wang, Hailin Jiang, Wenming Yang, Danqing Liu
article en

Abstract

Objective This study aimed to investigate the neuroprotective effects of Shao-Di-Pa-Ning Decoction (SDPND) in a Parkinson’s disease (PD) mouse model and explore its potential molecular mechanisms, with a particular focus on the regulation of SIRT3/PINK1/Parkin-associated mitochondrial quality-control signaling. Methods Ten-month-old male A53T mice were randomly assigned to the PD model group, SDPND low-, medium-, and high-dose groups (6.956, 13.91, and 27.82 g crude-herb equivalents/kg/day, respectively), and the levodopa/benserazide hydrochloride (LBHT) group (0.1 g/kg/day). Age-matched male C57BL/6 J mice served as the control group. All interventions were administered orally for four consecutive weeks. Behavioral tests, including the pole-climbing and hanging tests, were performed to evaluate motor dysfunction. Immunohistochemistry (IHC) and TUNEL staining were conducted to assess dopaminergic neuronal injury and apoptosis in the substantia nigra. Based on the pharmacological effects observed in the SDPND medium-dose group (13.91 g/kg/day), substantia nigra tissues from control, A53T model, and SDPND medium-dose-treated mice were subjected to transcriptomic sequencing. Differentially expressed genes were identified and analyzed using GO, KEGG, and PPI network analyses to explore the potential molecular mechanisms underlying SDPND-mediated neuroprotection. The effects of SDPND on mitochondrial function, oxidative stress, and mitophagy-related signaling were further validated using transmission electron microscopy (TEM), JC-1 staining, biochemical assays, quantitative real-time PCR (RT-qPCR), and Western blotting. Results SDPND significantly improved motor deficits in A53T mice, increased tyrosine hydroxylase (TH) expression, reduced abnormal α-synuclein accumulation, and attenuated DNA fragmentation in the substantia nigra. Transcriptomic analysis combined with GO, KEGG, and PPI analyses identified mitochondrial function and mitophagy-related pathways as potential targets of SDPND intervention, with SIRT3 emerging as a key regulatory candidate. Further validation demonstrated that SDPND improved mitochondrial morphology, enhanced mitochondrial membrane potential and ATP levels, reduced oxidative stress levels, and increased SIRT3, PINK1, and Parkin expression and the LC3-II/LC3-I ratio, while reducing p62 expression. Conclusion SDPND ameliorates motor dysfunction and neuronal injury in A53T mice. These neuroprotective effects are functionally associated with the modulation of SIRT3/PINK1/Parkin-related signaling and mitophagy-associated markers, alongside improved mitochondrial homeostasis and antioxidant capacity. These findings provide experimental evidence supporting the neuroprotective potential of SDPND, warranting further targeted mechanistic validation.

Frontiers in NeuroscienceVol. 20
Anhui University of Traditional Chinese Medicine (CN), Wangjing Hospital of China Academy of Chinese Medical Sciences (CN), China Academy of Chinese Medical Sciences (CN)
Anhui Agricultural University, Anhui University of Chinese Medicine, National Development and Reform Commission
Good health and well-being
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon